4635

Colorectal Diseases

Date

May 5, 2025

Explore related products in the following collection:

DDW 2025

Society: SSAT

Moderators

Luis Fernandez Torres Gil

Nikolaos Gouvas

Panepistemio Kyprou

University of California Irvine

Related Products

Thumbnail for ONGOING PHASE 1B/2 TRIAL OF THE ALLOSTERIC MEK1/2 INHIBITOR REC-4881 AS MONOTHERAPY IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP): PRELIMINARY SAFETY AND EFFICACY DATA

ONGOING PHASE 1B/2 TRIAL OF THE ALLOSTERIC MEK1/2 INHIBITOR REC-4881 AS MONOTHERAPY IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP): PRELIMINARY SAFETY AND EFFICACY DATA

Thumbnail for DUVAKITUG INDUCTION TREATMENT IMPROVES ENDOSCOPIC AND PATIENT-REPORTED CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE: AN ENDOSCOPIC SUBGROUP ANALYSIS OF DATA FROM THE RELIEVE-UCCD PHASE 2B STUDY

DUVAKITUG INDUCTION TREATMENT IMPROVES ENDOSCOPIC AND PATIENT-REPORTED CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE: AN ENDOSCOPIC SUBGROUP ANALYSIS OF DATA FROM THE RELIEVE-UCCD PHASE 2B STUDY

Thumbnail for International Symposium I: Together We Are Better - Colorectal Surgery Meets Abdominal Wall Reconstruction

International Symposium I: Together We Are Better - Colorectal Surgery Meets Abdominal Wall Reconstruction

SOCIETY: SSAT

Thumbnail for Colorectal Diseases II

Colorectal Diseases II

SOCIETY: SSAT